Amicus Therapeutics (FOLD) SEC Filings & 10K Form

$10.28
+0.11 (+1.08%)
(As of 04/26/2024 08:52 PM ET)

Recent Amicus Therapeutics SEC Filings

DateFilerForm TypeView
04/24/2024
3:31 PM
Amicus Therapeutics (Filer)
Form DEF 14A
04/24/2024
3:32 PM
Amicus Therapeutics (Filer)
Form DEFA14A
04/16/2024
4:42 PM
Amicus Therapeutics (Issuer)
Prout Samantha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2024
3:27 PM
Amicus Therapeutics (Subject)
Crowley John F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/03/2024
5:14 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
4:52 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
6:12 PM
Amicus Therapeutics (Issuer)
Castelli Jeff (Reporting)
Form 4/A
03/15/2024
6:13 PM
Amicus Therapeutics (Issuer)
Clark David Michael (Reporting)
Form 4/A
03/15/2024
6:14 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4/A
03/15/2024
6:15 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4/A
03/15/2024
6:10 PM
Amicus Therapeutics (Issuer)
Rosenberg Ellen (Reporting)
Form 4/A
03/11/2024
4:36 PM
Amicus Therapeutics (Issuer)
SBLENDORIO GLENN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
4:21 PM
Amicus Therapeutics (Issuer)
MCGLYNN MARGARET G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
4:22 PM
Amicus Therapeutics (Issuer)
RAAB MICHAEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
4:35 PM
Amicus Therapeutics (Subject)
MCGLYNN MARGARET G (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
3:39 PM
Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
3:33 PM
Amicus Therapeutics (Subject)
Crowley John F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2024
6:02 AM
Amicus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2024
4:21 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2024
4:23 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
3:19 PM
Amicus Therapeutics (Subject)
Clark David Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/15/2024
3:19 PM
Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2024
8:22 AM
Amicus Therapeutics (Subject)
Avoro Capital Advisors LLC (Filed by)
Form SC 13G/A
02/08/2024
3:40 PM
Amicus Therapeutics (Issuer)
Rosenberg Ellen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:22 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:22 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2024
3:44 PM
Amicus Therapeutics (Subject)
Crowley John F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/01/2024
3:45 PM
Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/24/2024
4:20 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2024
3:18 PM
Amicus Therapeutics (Subject)
Crowley John F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/18/2024
4:09 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2024
3:25 PM
Amicus Therapeutics (Subject)
Crowley John F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/11/2024
5:33 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2024
5:34 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2024
5:34 PM
Amicus Therapeutics (Issuer)
Castelli Jeff (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2024
5:35 PM
Amicus Therapeutics (Issuer)
Clark David Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2024
5:35 PM
Amicus Therapeutics (Issuer)
Rosenberg Ellen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
3:06 PM
Amicus Therapeutics (Subject)
Crowley John F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
5:07 PM
Amicus Therapeutics (Issuer)
Prout Samantha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
5:08 PM
Amicus Therapeutics (Issuer)
Clark David Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
3:27 PM
Amicus Therapeutics (Subject)
Clark David Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
The “Next Bitcoin”? 10 CENT Crypto Set to Explode (Ad)

The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…

Click For My #1 FREE Crypto for 2024
01/09/2024
3:27 PM
Amicus Therapeutics (Subject)
Prout Samantha (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
8:09 AM
Amicus Therapeutics (Subject)
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Form SC 13G
01/08/2024
6:01 AM
Amicus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2024
5:01 PM
Amicus Therapeutics (Issuer)
Prout Samantha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
5:01 PM
Amicus Therapeutics (Issuer)
Clark David Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
5:02 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
5:03 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
5:03 PM
Amicus Therapeutics (Issuer)
Rosenberg Ellen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
5:04 PM
Amicus Therapeutics (Issuer)
Castelli Jeff (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
5:24 PM
Amicus Therapeutics (Issuer)
Rosenberg Ellen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
5:26 PM
Amicus Therapeutics (Issuer)
Clark David Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
5:33 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
5:35 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
5:36 PM
Amicus Therapeutics (Issuer)
Castelli Jeff (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
5:17 PM
Amicus Therapeutics (Issuer)
Harford Simon N.R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
5:30 PM
Amicus Therapeutics (Issuer)
Prout Samantha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
3:32 PM
Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/02/2024
3:32 PM
Amicus Therapeutics (Subject)
Rosenberg Ellen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/29/2023
4:18 PM
Amicus Therapeutics (Issuer)
Amicus Therapeutics (Issuer)
Castelli Jeff (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2023
4:08 PM
Amicus Therapeutics (Issuer)
Rosenberg Ellen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2023
4:09 PM
Amicus Therapeutics (Issuer)
Prout Samantha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2023
3:21 PM
Amicus Therapeutics (Subject)
Castelli Jeff (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/26/2023
3:25 PM
Amicus Therapeutics (Subject)
Rosenberg Ellen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/26/2023
3:25 PM
Amicus Therapeutics (Subject)
Prout Samantha (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/20/2023
3:41 PM
Amicus Therapeutics (Issuer)
Castelli Jeff (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
3:20 PM
Amicus Therapeutics (Subject)
Castelli Jeff (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/19/2023
4:54 PM
Amicus Therapeutics (Issuer)
Clark David Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
4:55 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
4:56 PM
Amicus Therapeutics (Issuer)
Rosenberg Ellen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
4:58 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2023
3:37 PM
Amicus Therapeutics (Subject)
Crowley John F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/08/2023
3:31 PM
Amicus Therapeutics (Subject)
MORGAN STANLEY (Filed by)
Form SC 13G/A
12/05/2023
4:03 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
4:07 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
5:03 AM
Amicus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/17/2023
4:23 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2023
4:25 PM
Amicus Therapeutics (Filer)
Form S-3ASR
11/08/2023
6:00 AM
Amicus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/03/2023
6:37 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/03/2023
6:38 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2023
6:57 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2023
3:23 PM
Amicus Therapeutics (Subject)
Crowley John F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/05/2023
4:00 PM
Amicus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2023
5:58 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2023
5:57 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2023
3:11 PM
Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/02/2023
3:13 PM
Amicus Therapeutics (Subject)
Crowley John F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/02/2023
7:48 AM
Amicus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/28/2023
11:00 AM
Amicus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2023
6:00 AM
Amicus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (Ad)

If you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)

Watch my video for all of the details
09/18/2023
4:09 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2023
3:10 PM
Amicus Therapeutics (Subject)
Quimi Daphne (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2023
3:13 PM
Amicus Therapeutics (Subject)
Quimi Daphne (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/06/2023
4:29 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
4:31 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2023
3:11 PM
Amicus Therapeutics (Subject)
Crowley John F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/01/2023
3:19 PM
Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/23/2023
4:46 PM
Amicus Therapeutics (Issuer)
Harford Simon N.R. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/23/2023
4:59 PM
Amicus Therapeutics (Issuer)
Harford Simon N.R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:FOLD) was last updated on 4/29/2024 by MarketBeat.com Staff

From Our Partners